Physician Profile
Keith M. Benbenisty, M.D. practices mohs surgery / dermatologic surgery in Fort Myers, FL. Keith is a 2000 graduate of Medical College of Georgia School of Medicine. According to Medicare claims data, Keith cared for 6,929 Medicare patients across 21,246 services. The services billed most often include injection, tildrakizumab, 1 mg, destruction of precancer skin growth, 2-14 growths, and established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more.
Summarised automatically from public NPI registry and CMS Medicare data. Not written or reviewed by this provider. Claim this profile to replace it — free, and no identity document with a practice or institutional email.
License numbers are what the provider reported to NPPES when the NPI was issued or updated. NPPES does not verify licensure; confirm current standing with the state licensing board.
Exactly as CMS reports it (National Downloadable File, Opt-Out Affidavits, Order & Referring). Not an insurance directory; confirm coverage with the office.
8381 RIVERWALK PARK BLVD SUITE 101
Fort Myers, FL 33919
21,246 services · 6,929 patients · 25 distinct codes
| Procedure | Type | Code | Services | Compared with peers |
|---|---|---|---|---|
| Destruction of precancer skin growth, 2-14 growths | Procedure | 17003 |
3,509 | More than most peers in Mohs Surgery / Dermatologic… |
| Destruction of precancer skin growth, 1 growth | Procedure | 17000 |
1,588 | More than most peers in Mohs Surgery / Dermatologic… |
| Biopsy of related skin growth, first growth | Procedure | 11102 |
1,280 | More than most peers in Mohs Surgery / Dermatologic… |
| Destruction of skin growth, 1-14 growths | Procedure | 17110 |
655 | More than most peers in Mohs Surgery / Dermatologic… |
| Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Procedure | 17261 |
383 | More than most peers in Mohs Surgery / Dermatologic… |
| Biopsy of related skin growth, each additional growth | Procedure | 11103 |
353 | More than most peers in Mohs Surgery / Dermatologic… |
| Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Procedure | 17262 |
333 | More than most peers in Mohs Surgery / Dermatologic… |
| Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Procedure | 17281 |
141 | More than most peers in Mohs Surgery / Dermatologic… |
| Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm | Procedure | 17271 |
107 | More than most peers in Mohs Surgery / Dermatologic… |
| Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Procedure | 11642 |
98 | More often than most peers in Mohs Surgery / Dermatologic… |
Source: CMS Medicare public data. Shows how often procedures were billed — not quality of care or patient satisfaction.
Keith M. Benbenisty is a mohs surgery / dermatologic surgeon in Fort Myers, FL. That is the designation recorded for this NPI in the federal registry, where it is listed as “Mohs Surgery / Dermatologic Surgery”.
NPI registry
Keith M. Benbenisty is listed at 8381 Riverwalk Park Blvd Suite 101, Fort Myers, FL 33919. Addresses come from the NPI registry and can lag a move, so confirm before travelling.
NPI registry
The number on file is (239) 936-5425. Guide.md cannot book appointments or pass on messages — please call the office directly.
NPI registry
Keith M. Benbenisty's National Provider Identifier is 1265495782. It is issued by the Centers for Medicare & Medicaid Services and is unique and permanent — it does not change if they move practice.
NPI registry
Keith M. Benbenisty attended Medical College of Georgia School of Medicine, graduating in 2000. This comes from the CMS National Downloadable File.
CMS public data
Keith M. Benbenisty has 26 years experience. Calculated from a graduation year of 2000, reported in the CMS National Downloadable File.
CMS public data
According to Medicare billing data, Keith M. Benbenisty performs procedures including destruction of precancer skin growth, 2-14 growths, destruction of precancer skin growth, 1 growth and biopsy of related skin growth, first growth; provides treatments such as injection of drug or substance under skin or into muscle and application of light to destroy precancer skin growth, alongside routine visits and testing. This reflects Medicare patients only and is billing volume, not a measure of quality.
Medicare claims
Not yet. This profile is built from public federal data and has not been confirmed by Keith M. Benbenisty. If this is you, claiming it is free.
Guide.md
Provider data sourced from the NPPES NPI Registry and CMS public datasets. Information is provided for reference and is not medical advice.